Topical Day | Medical applications of ISOL@MYRRHA

November 25, 2014   Mol (BELGIUM)

  • Introduction to ISOL@MYRRHA project
  • The NuPECC Report "Nuclear Physics for medicine"
  • Medical imaging
  • Medical Applications of High-Power ISOL Facilities
  • Targeted alpha therapy and the 211At programme
  • Preclinical imaging and therapy (review of all peptide- and protein-based radiopharmaceuticals)
  • The production of Tb-radionuclides for diagnostic and therapeutic application in nuclear medicine